Organization
Grin Therapeutics
2 clinical trials
Clinical trial
A Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms of Radiprodil in Patients With Tuberous Sclerosis Complex (TSC) or Focal Cortical Dysplasia (FCD) Type IIStatus: Recruiting, Estimated PCD: 2025-07-01
Clinical trial
A Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms of Multiple Individually Titrated Doses of Radiprodil in Children With GRIN-related DisorderStatus: Recruiting, Estimated PCD: 2025-11-01